Hyperion Therapeutics Raises $60 Million
Posted on: July 5, 2009 by PEHub AdministratorNo Comments »
Hyperion Therapeutics, a San Francisco-based drug company focused on gastroenterology and hepatology, has raised $60 million in Series C funding. Bay City Capital and Panorama Capital co-led the round, and were joined by return backers Highland Capital Partners, New Enterprise Associates and Sofinnova Ventures. PRESS RELEASE Hyperion Therapeutics, a privately held specialty pharmaceutical company focused on [...]
